Imidazolone anorectic agents: iii. heteroaryl derivatives
CA 2325472 A1 · Owner: Poindexter, Graham S. · Inventors: Gillman, Kevin; Poindexter, Graham S.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A series of non-peptidergic antagonists of NPY have been synthesized and are comprised of heteroaryl derivatives of imidazolone compounds of Formula (I). As antagonists of NPY-induced feeding behavior these compounds and known , analogs are expected to act as effective anorexiant agents in promoting weight loss and treating eating disorders.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 3, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 3, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 3, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.